{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:50:47Z","timestamp":1792590647649,"version":"4.5.0"},"reference-count":41,"publisher":"MyJove Corporation","issue":"232","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70985","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:00:34Z","timestamp":1781046034000},"source":"Crossref","is-referenced-by-count":0,"title":["Treatment-Related Cystitis During Intravesical Chemotherapy: Incidence, Risk Factors, And Nursing-Pathway Associations"],"prefix":"10.3791","author":[{"given":"Jiali","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baochuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengpeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehui","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/JU.0000000000004472","type":"journal-article","article-title":"Gemcitabine vs Bacillus Calmette-Gu\u00e9rin for intravesical therapy in treatment-na\u00efve low-grade intermediate-risk nonmuscle-invasive bladder cancer","volume":"213","author":"Khene","year":"2025","unstructured":"Khene ZE et al. Gemcitabine vs Bacillus Calmette-Gu\u00e9rin for intravesical therapy in treatment-na\u00efve low-grade intermediate-risk nonmuscle-invasive bladder cancer. J Urol. 2025;213(6):730-738.","journal-title":"J Urol"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","type":"journal-article","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","unstructured":"Holzbeierlein JM et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment. J Urol. 2024;211(4):533-538.","journal-title":"J Urol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"20241134","DOI":"10.1515\/med-2024-1134","type":"journal-article","article-title":"The safety and efficacy of BCG combined with mitomycin C compared with BCG monotherapy in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"20","author":"Liu","year":"2025","unstructured":"Liu J et al. The safety and efficacy of BCG combined with mitomycin C compared with BCG monotherapy in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Open Med (Wars). 2025;20(1):20241134.","journal-title":"Open Med (Wars)"},{"issue":"24","key":"ref4","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.3390\/cancers16244125","type":"journal-article","article-title":"Comparisons of intravesical treatments with mitomycin C, gemcitabine, and docetaxel for recurrence and progression of non-muscle invasive bladder cancer: updated systematic review and meta-analysis","volume":"16","author":"Matloubieh","year":"2024","unstructured":"Matloubieh JE, Hanelin D, Agalliu I. Comparisons of intravesical treatments with mitomycin C, gemcitabine, and docetaxel for recurrence and progression of non-muscle invasive bladder cancer: updated systematic review and meta-analysis. Cancers (Basel). 2024;16(24):4125.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40261-015-0306-6","type":"journal-article","article-title":"Intravesical glycosaminoglycan replacement with chondroitin sulphate (Gepan instill) in patients with chronic radiotherapy- or chemotherapy-associated cystitis","volume":"35","author":"Schwalenberg","year":"2015","unstructured":"Schwalenberg T et al. Intravesical glycosaminoglycan replacement with chondroitin sulphate (Gepan instill) in patients with chronic radiotherapy- or chemotherapy-associated cystitis. Clin Drug Investig. 2015;35(8):505-512.","journal-title":"Clin Drug Investig"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/bju.16716","type":"journal-article","article-title":"Assessing the efficacy and safety of sequential intravesical gemcitabine and docetaxel: does time from transurethral resection of bladder tumour to induction matter?","volume":"136","author":"McElree","year":"2025","unstructured":"McElree IM et al. Assessing the efficacy and safety of sequential intravesical gemcitabine and docetaxel: does time from transurethral resection of bladder tumour to induction matter? BJU Int. 2025;136(1):42-44.","journal-title":"BJU Int"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s40487-025-00375-x","type":"journal-article","article-title":"The impact of intravesical instillations on quality of life in patients with non-muscle-invasive bladder cancer: a systematic review","volume":"13","author":"Griebsch","year":"2025","unstructured":"Griebsch I et al. The impact of intravesical instillations on quality of life in patients with non-muscle-invasive bladder cancer: a systematic review. Oncol Ther. 2025;13(4):895-918.","journal-title":"Oncol Ther"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1179\/1973947813Y.0000000126","type":"journal-article","article-title":"The quality of life in patients during intravesical treatment and correlation with local symptoms","volume":"26","author":"Wei","year":"2014","unstructured":"Wei L, Li Q, Liang H, Li J. The quality of life in patients during intravesical treatment and correlation with local symptoms. J Chemother. 2014;26(3):165-168.","journal-title":"J Chemother"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.eursup.2008.08.001","type":"journal-article","article-title":"Clinical practice recommendations for the prevention and management of intravesical therapy-associated adverse events","volume":"7","author":"Witjes","year":"2008","unstructured":"Witjes JA et al. Clinical practice recommendations for the prevention and management of intravesical therapy-associated adverse events. Eur Urol Suppl. 2008;7(10):667-674.","journal-title":"Eur Urol Suppl"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","type":"journal-article","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","unstructured":"Benchimol EI et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.","journal-title":"PLoS Med"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","type":"journal-article","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","unstructured":"von Elm E et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573-577.","journal-title":"Ann Intern Med"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"e36871","DOI":"10.1097\/MD.0000000000036871","type":"journal-article","article-title":"Effectiveness of integrated nursing interventions in enhancing patient outcomes during postoperative intravesical instillation for non-muscle invasive bladder cancer: a comparative study","volume":"103","author":"Wang","year":"2024","unstructured":"Wang W, Chen Y, Gu J. Effectiveness of integrated nursing interventions in enhancing patient outcomes during postoperative intravesical instillation for non-muscle invasive bladder cancer: a comparative study. Medicine (Baltimore). 2024;103(11):e36871.","journal-title":"Medicine (Baltimore)"},{"key":"ref13","article-title":"Intravesical administration of therapeutic medication for the treatment of bladder cancer","year":"2020","unstructured":"American Urological Association, Society of Urologic Nurses and Associates. Intravesical administration of therapeutic medication for the treatment of bladder cancer. American Urological Association. Available at: https:\/\/www.auanet.org\/about-us\/aua-statements\/intravesical-administration-of-therapeutic-medication. 2020."},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.23736\/S2724-5691.23.10162-6","type":"journal-article","article-title":"Symptom management and nursing interventions for postoperative bladder instillation chemotherapy in bladder cancer patients","volume":"79","author":"Wang","year":"2024","unstructured":"Wang L, Wang W. Symptom management and nursing interventions for postoperative bladder instillation chemotherapy in bladder cancer patients. Minerva Surg. 2024;79(3):392-394.","journal-title":"Minerva Surg"},{"issue":"1","key":"ref15","first-page":"44","type":"journal-article","article-title":"Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition)","volume":"9","author":"Jin","year":"2022","unstructured":"Jin YH et al. Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition). Mil Med Res. 2022;9(1):44.","journal-title":"Mil Med Res"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.5811\/westjem.2011.11.6810","type":"journal-article","article-title":"Current trends in the management of difficult urinary catheterizations","volume":"13","author":"Willette","year":"2012","unstructured":"Willette PA, Coffield S. Current trends in the management of difficult urinary catheterizations. West J Emerg Med. 2012;13(6):472-478.","journal-title":"West J Emerg Med"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1093\/cid\/ciy1121","type":"journal-article","article-title":"Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America","volume":"68","author":"Nicolle","year":"2019","unstructured":"Nicolle LE et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68(10):e83-e110.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ucl.2013.01.005","type":"journal-article","article-title":"Side effects of perioperative intravesical treatment and treatment strategies for these side effects","volume":"40","author":"Griffin","year":"2013","unstructured":"Griffin JG, Holzbeierlein J. Side effects of perioperative intravesical treatment and treatment strategies for these side effects. Urol Clin North Am. 2013;40(2):197-210.","journal-title":"Urol Clin North Am"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3390\/jcm12041495","type":"journal-article","article-title":"Urethral injuries: diagnostic and management strategies for critical care and trauma clinicians","volume":"12","author":"Patel","year":"2023","unstructured":"Patel AB et al. Urethral injuries: diagnostic and management strategies for critical care and trauma clinicians. J Clin Med. 2023;12(4):1495.","journal-title":"J Clin Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1748-5908-2-40","type":"journal-article","article-title":"A conceptual framework for implementation fidelity","volume":"2","author":"Carroll","year":"2007","unstructured":"Carroll C et al. A conceptual framework for implementation fidelity. Implement Sci. 2007;2:40.","journal-title":"Implement Sci"},{"key":"ref21","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0","year":"2017","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0. National Cancer Institute; 2017.","type":"book"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3233\/BLC-160089","type":"journal-article","article-title":"A management algorithm for mitomycin C induced cystitis","volume":"3","author":"Luckenbaugh","year":"2017","unstructured":"Luckenbaugh AN et al. A management algorithm for mitomycin C induced cystitis. Bladder Cancer. 2017;3(2):133-138.","journal-title":"Bladder Cancer"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3892\/etm.2021.10056","type":"journal-article","article-title":"Chemical hemorrhagic cystitis: diagnostic and therapeutic pitfalls","volume":"21","author":"Petca","year":"2021","unstructured":"Petca RC et al. Chemical hemorrhagic cystitis: diagnostic and therapeutic pitfalls. Exp Ther Med. 2021;21(6):624.","journal-title":"Exp Ther Med"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1080\/03007995.2024.2411424","type":"journal-article","article-title":"Overall burden and impact on health-related quality of life associated with intravesical treatment of patients with non-muscle invasive bladder cancer in the United States","volume":"40","author":"Totev","year":"2024","unstructured":"Totev TI et al. Overall burden and impact on health-related quality of life associated with intravesical treatment of patients with non-muscle invasive bladder cancer in the United States. Curr Med Res Opin. 2024;40(11):2003-2011.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","type":"journal-article","article-title":"The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society","volume":"61","author":"Abrams","year":"2003","unstructured":"Abrams P et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37-49.","journal-title":"Urology"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","type":"journal-article","article-title":"Validity and reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","unstructured":"Dueck AC et al. Validity and reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 2015;1(8):1051-1059.","journal-title":"JAMA Oncol"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","type":"journal-article","article-title":"European Association of Urology guidelines on urological infections: summary of the 2024 guidelines","volume":"86","author":"Kranz","year":"2024","unstructured":"Kranz J et al. European Association of Urology guidelines on urological infections: summary of the 2024 guidelines. Eur Urol. 2024;86(1):27-41.","journal-title":"Eur Urol"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","type":"journal-article","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399-424.","journal-title":"Multivariate Behav Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","type":"journal-article","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","unstructured":"Sterne JA et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.","journal-title":"BMJ"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0022-5347(06)00264-3","type":"journal-article","article-title":"Complications of intravesical therapy for urothelial cancer of the bladder","volume":"175","author":"Koya","year":"2006","unstructured":"Koya MP, Simon MA, Soloway MS. Complications of intravesical therapy for urothelial cancer of the bladder. J Urol. 2006;175(6):2004-2010.","journal-title":"J Urol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.urology.2020.10.039","type":"journal-article","article-title":"Side effects of intravesical BCG and chemotherapy for bladder cancer: what they are and how to manage them","volume":"149","author":"Koch","year":"2021","unstructured":"Koch GE, Smelser WW, Chang SS. Side effects of intravesical BCG and chemotherapy for bladder cancer: what they are and how to manage them. Urology. 2021;149:11-20.","journal-title":"Urology"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/bco2.203","type":"journal-article","article-title":"Hyperthermic intravesical chemotherapy with mitomycin-C for the treatment of high-risk non-muscle-invasive bladder cancer patients","volume":"4","author":"Conroy","year":"2022","unstructured":"Conroy S et al. Hyperthermic intravesical chemotherapy with mitomycin-C for the treatment of high-risk non-muscle-invasive bladder cancer patients. BJUI Compass. 2022;4(3):314-321.","journal-title":"BJUI Compass"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.euo.2024.05.006","type":"journal-article","article-title":"Safety and efficacy of immediate hyperthermic intravesical chemotherapy following transurethral resection of bladder tumour (I-HIVEC)","volume":"7","author":"Wong","year":"2024","unstructured":"Wong CH et al. Safety and efficacy of immediate hyperthermic intravesical chemotherapy following transurethral resection of bladder tumour (I-HIVEC). Eur Urol Oncol. 2024;7(6):1171-1174.","journal-title":"Eur Urol Oncol"},{"key":"ref34","type":"book","volume-title":"Difficult foley catheterization. StatPearls","author":"Bianchi","year":"2023","unstructured":"Bianchi A, Leslie SW, Chesnut GT. Difficult foley catheterization. StatPearls. Treasure Island, FL: StatPearls Publishing; 2023."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1327053","DOI":"10.3389\/fnins.2023.1327053","type":"journal-article","article-title":"BCG induced lower urinary tract symptoms during treatment for NMIBC-mechanisms and management strategies","volume":"17","author":"Bourlotos","year":"2024","unstructured":"Bourlotos G et al. BCG induced lower urinary tract symptoms during treatment for NMIBC-mechanisms and management strategies. Front Neurosci. 2024;17:1327053.","journal-title":"Front Neurosci"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"e70117","DOI":"10.1002\/bco2.70117","type":"journal-article","article-title":"Time to abandon routine urine analysis prior to Bacillus Calmette-Gu\u00e9rin administration in asymptomatic patients","volume":"6","author":"Nummi","year":"2025","unstructured":"Nummi A et al. Time to abandon routine urine analysis prior to Bacillus Calmette-Gu\u00e9rin administration in asymptomatic patients. BJUI Compass. 2025;6(12):e70117.","journal-title":"BJUI Compass"},{"key":"ref37","first-page":"301","type":"journal-article","article-title":"Nursing audit as a method for developing nursing care and ensuring patient safety","volume":"2012","author":"Mykk\u00e4nen","year":"2012","unstructured":"Mykk\u00e4nen M, Saranto K, Miettinen M. Nursing audit as a method for developing nursing care and ensuring patient safety. NI 2012. 2012;2012:301.","journal-title":"NI 2012"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1007\/s00345-019-02737-3","type":"journal-article","article-title":"The risk factors of urinary tract infection after transurethral resection of bladder tumors","volume":"37","author":"Kohada","year":"2019","unstructured":"Kohada Y, Goriki A, Yukihiro K, Ohara S, Kajiwara M. The risk factors of urinary tract infection after transurethral resection of bladder tumors. World J Urol. 2019;37(12):2715-2719.","journal-title":"World J Urol"},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3390\/ph16071031","type":"journal-article","article-title":"Lower urinary tract disorders as adverse drug reactions: a literature review","volume":"16","author":"Dobrek","year":"2023","unstructured":"Dobrek L. Lower urinary tract disorders as adverse drug reactions: a literature review. Pharmaceuticals (Basel). 2023;16(7):1031.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"e21200038","DOI":"10.14440\/bladder.2024.0066","type":"journal-article","article-title":"Hyaluronic acid as a treatment for refractory Bacillus Calmette-Gu\u00e9rin-induced cystitis: a narrative review","volume":"12","author":"Gomati","year":"2025","unstructured":"Gomati A, Teggaz M, Allam M, Mahmalji W. Hyaluronic acid as a treatment for refractory Bacillus Calmette-Gu\u00e9rin-induced cystitis: a narrative review. Bladder (San Franc). 2025;12(2):e21200038.","journal-title":"Bladder (San Franc)"},{"issue":"19","key":"ref41","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.3390\/jcm14196908","type":"journal-article","article-title":"Association between baseline neutrophil-to-lymphocyte ratio and short-term urinary quality of life during BCG induction in male patients with non-muscle-invasive bladder cancer: a prospective observational study","volume":"14","author":"Spirito","year":"2025","unstructured":"Spirito L et al. Association between baseline neutrophil-to-lymphocyte ratio and short-term urinary quality of life during BCG induction in male patients with non-muscle-invasive bladder cancer: a prospective observational study. J Clin Med. 2025;14(19):6908.","journal-title":"J Clin Med"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/70985\/treatment-related-cystitis-during-intravesical-chemotherapy-incidence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:34:07Z","timestamp":1792589647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70985\/treatment-related-cystitis-during-intravesical-chemotherapy-incidence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":41,"journal-issue":{"issue":"232","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70985","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]}}}